Table 3.

Comparison for baseline severity of disease, demographics and mortality between patients with Runx1p66/p52 high ratio vs. patients Runx1p66 negative or low Runx1p66/p52 ratio

	Runx1 p66/p52 high ratio	Low Runx1 p66/p52 ratio or p66 negative	p value
No.	17	12	–
Mortality	3 (17.6%)	7 (58.33)	0.023 (OR = 5.15)
Age	41.76 ± 6.4	50.25 ± 9.4	0.142
Sex	10F/7M	5F/7M	0.362
SAPS II	47.23 ± 6.9	53.33 ± 7.25	0.254
APACHE II	23 ± 3	25.5 ± 4.35	0.349
SOFA	10.94 ± 1.58	13.08 ± 2.18	0.124
Lung Injury Score	2.91 ± 0.33	3.09 ± 0.49	0.574
P/F ratio at onset of ARDS	118.13 ± 25.04	96.04 ± 19.21	0.213
ICU length of stay	28.76 ± 10.05	22.42 ± 13.66	0.460

APACHE II Acute Physiology and Chronic Health Evaluation II; SAPS II Simplified Acute Physiology Score II, SOFA Sequential Organ Failure Assessment score, LIS Lung Injury Score, P/F PaO₂/FiO₂ ratio on the day of diagnosis of ARDS; Values are mean ± SD